Ads
related to: qutenza patch for shingles painassistantmagic.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Acorda Therapeutics Announces Acquisition of Two Neuropathic Pain Assets Qutenza® (capsaicin) 8% Patch FDA-Approved Therapy for Neuropathic Pain Associated with Postherpetic Neuralgia Phase 3 ...
With resolution of the herpes zoster eruption, pain that continues for three months or more is defined as postherpetic neuralgia. Pain is variable, from discomfort to very severe, and may be described as burning, stabbing, or gnawing. Signs: [citation needed] Area of previous herpes zoster may show evidence of cutaneous scarring.
A capsaicin transdermal patch (Qutenza) for the management of this particular therapeutic indication (pain due to post-herpetic neuralgia) was approved in 2009, as a therapeutic by both the U.S. Food and Drug Administration (FDA) [17] [18] and the European Union. [19]
Feeling pain in the early stages of a shingles infection. A weak immune system. Other long-term difficulties that can develop include the following: Vertigo. Problems with eyesight. Hepatitis.
NeurogesX has successfully completed three Phase III clinical studies of Qutenza that met studies primary endpoints. Qutenza is a synthetic trans-capsaicin and drug delivery is by a rapid-delivery patch application system [36] NeurogesX plans to launch Qutenza in the United States in the first half of November 2010. [37]
Medicare may cover Qutenza if a doctor has prescribed the medication and the pharmacy a person uses accepts Medicare. Learn about other options here.
Ads
related to: qutenza patch for shingles painassistantmagic.com has been visited by 10K+ users in the past month